Pyrimidine Synthesis Inhibitor [EPC]

This page covers all Pyrimidine Synthesis Inhibitor [EPC] drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting dihydroorotate dehydrogenase, Dihydroorotate dehydrogenase.

Targets

dihydroorotate dehydrogenase · Dihydroorotate dehydrogenase

Marketed (1)

• Aubagio · Sanofi · Immunology · 1100
  Teriflunomide inhibits dihydroorotate dehydrogenase, reducing activated lymphocytes in the CNS.

Phase 2 pipeline (1)

• Gimeracil and Oteracil Porassium Capsules · Beijing Biohealthcare Biotechnology Co.,Ltd · Oncology
  Inhibits dihydroorotate dehydrogenase

Patent intelligence

• pyrimidine synthesis inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates